首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷分子呈像/呈影劑

市場調查報告書

商品編碼

1547495

全球造影注射器市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Contrast Injector Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 130 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球造影劑注射器市場需求預計將從 2023 年的 101526 萬美元達到 2032 年近 215814 萬美元的市場規模，2024-2032 年研究期間複合年成長率為 8.74%。

造影劑注射器是一種用於在 MRI 掃描期間靜脈注射顯影劑的機器，因為它可以提高體內靜脈、動脈和組織的可見度。該設備有助於在整個成像過程中保持平滑且受控的對比度流動。它用於微創外科手術，因為它提供手術部位的高品質影像，從而幫助外科醫生在適當的位置進行手術。電腦化版本被辨識為自動注射器。它能夠控制注射的造影劑的量以及利用率。對於自動注射器，可以根據醫學影像掃描儀的速度來調整造影劑的劑量。

市場動態

微創手術數量的增加、慢性、心臟、骨科和神經系統疾病發病率的增加以及診斷中心數量的增加是造影劑注射器市場成長的一些關鍵促進因素。促進市場成長的其他因素包括政府機構的批准、政府組織的撥款以及與造影劑相關的投資的增加。此外，造影劑注射器領域的技術進步將使醫學影像變得更好並推動市場成長。然而，與造影劑注射器和配件相關的高成本以及將造影劑放入注射器內的風險預計將在一定程度上阻礙市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球造影注射器市場的各個細分市場進行了包容性評估。造影劑注射器產業的成長和趨勢為本研究提供了整體方法。

市場區隔

造影劑注射器市場報告的這一部分提供了有關國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品分類

噴射器系統
耗材
配件

按申請

放射科
介入性心臟病學
介入放射學

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲對比注射器市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。造影劑注射器市場的主要參與者包括拜耳醫療保健、GE醫療保健、Bracco Imaging SPA、AngioDynamics、Medtron AG、Ulrich GmbH & Co. KG、Guerbet Group、Vivid Imaging、Sino Medical Device Technology Co. Ltd.、Apollo RT Co. Ltd.、Apollo RT Co. Ltd.。、以及其他進展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：造影劑注射器公司的競爭格局

造影劑注射器市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
Bayer HealthCare

公司概況
公司收入
產品
最新動態

GE Healthcare

公司概況
公司收入
產品
最新動態

Bracco Imaging SPA

公司概況
公司收入
產品
最新動態

AngioDynamics

公司概況
公司收入
產品
最新動態

Medtron AG

公司概況
公司收入
產品
最新動態

Ulrich GmbH & Co. KG

公司概況
公司收入
產品
最新動態

Guerbet Group

公司概況
公司收入
產品
最新動態

Vivid Imaging

公司概況
公司收入
產品
最新動態

Sino Medical Device Technology Co. Ltd.

公司概況
公司收入
產品
最新動態

Apollo RT Co. Ltd.

公司概況
公司收入
產品
最新動態

Nemoto Kyorindo Co. Ltd

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11215162

The global demand for Contrast Injector Market is presumed to reach the market size of nearly USD 2158.14 Million by 2032 from USD 1015.26 Million in 2023 with a CAGR of 8.74% under the study period 2024-2032.

Contrast injector is a machine used for injecting contrast agents intravenously during MRI scans as it improves visibility of veins, arteries, and tissues present in the body. The device helps to maintain a smooth and controlled flow of contrast throughout the imaging process. It is used in minimally invasive surgical procedures, as it provides high-quality images of the surgical site, thereby helping surgeons to operate in the appropriate place. The computerized version is identified as auto-injectors. It has the ability to control the amount of contrast media that is injected and also the utilization rate. For auto-injectors, the dose of contrast media can be adjusted depending on how fast the medical imaging scanner is.

MARKET DYNAMICS

The rise in the number of minimally-invasive surgeries, increasing incidence of chronic, cardiac, orthopedic and neurological diseases and an increase in the number of diagnostic centers are some key driving factors for contrast media injector market growth. Other factors contributing to the market growth are approvals by government bodies, grants from government organizations, and growing investment related to contrast media. Furthermore, technological advancements in the contrast media injector field will make medical imaging even better and fuel market growth. However, the high cost associated with contrast media injectors and accessories and the risk of putting contrast media inside the injector is expected to hamper the market growth to some extent.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Contrast Injector. The growth and trends of Contrast Injector industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Contrast Injector market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Injector Systems
Consumables
Accessories

By Application

Radiology
Interventional Cardiology
Interventional Radiology

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Contrast Injector market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Contrast Injector market include Bayer HealthCare, GE Healthcare, Bracco Imaging S.P.A., AngioDynamics, Medtron AG, Ulrich GmbH & Co. KG, Guerbet Group, Vivid Imaging, Sino Medical Device Technology Co. Ltd., Apollo RT Co. Ltd., Nemoto Kyorindo Co. Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CONTRAST INJECTOR - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CONTRAST INJECTOR MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Injector Systems Historic and Forecast Sales By Regions
5.4. Consumables Historic and Forecast Sales By Regions
5.5. Accessories Historic and Forecast Sales By Regions

6. GLOBAL CONTRAST INJECTOR MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Radiology Historic and Forecast Sales By Regions
6.4. Interventional Cardiology Historic and Forecast Sales By Regions
6.5. Interventional Radiology Historic and Forecast Sales By Regions

7. GLOBAL CONTRAST INJECTOR MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE CONTRAST INJECTOR COMPANIES

8.1. Contrast Injector Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF CONTRAST INJECTOR INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Bayer HealthCare
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. GE Healthcare
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Bracco Imaging S.P.A.
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. AngioDynamics
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Medtron AG
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Ulrich GmbH & Co. KG
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Guerbet Group
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Vivid Imaging
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Sino Medical Device Technology Co. Ltd.
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Apollo RT Co. Ltd.
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments
9.13. Nemoto Kyorindo Co. Ltd
- 9.13.1 Company Overview
- 9.13.2 Company Revenue
- 9.13.3 Products
- 9.13.4 Recent Developments